HEM Pharma Inc. (KOSDAQ:376270)

South Korea flag South Korea · Delayed Price · Currency is KRW
52,000
-1,000 (-1.89%)
At close: Dec 5, 2025
302.48%
Market Cap 367.57B
Revenue n/a
Net Income n/a
Shares Out 7.07M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 95,465
Average Volume 95,587
Open 52,900
Previous Close 53,000
Day's Range 48,350 - 53,700
52-Week Range 11,600 - 59,000
Beta n/a
RSI 80.40
Earnings Date Nov 26, 2025

About HEM Pharma

HEM Pharma Inc. operates as a microbiome healthcare company in South Korea and internationally. The company offers health functional food products, such as Nutrilite and my LAB microbiome solution. It also engages in the personalized analysis service and CDMO businesses. The company was founded in 2016 and is based in Pohang-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2016
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 376270
Full Company Profile

News

There is no news available yet.